HomeOpen Access News

Open Access News

UK Government updates NHS IP guidance for the first time in 23 years

New updates to the NHS intellectual property (IP) guidance will improve access to new treatments more quickly.

New NHS programme boosts health support for Armed Forces community

A major £1.8 million training initiative across English NHS trusts will equip staff to identify and support veterans, reservists and their families, marking every trust as ‘Veteran Aware’.

Understanding the science projects receiving the synergy grants 2025

Sixty-six research teams, comprising 239 scientists from around the globe, will receive a total of €684 million in Synergy Grants 2025 from the European Research Council (ERC).

UK invests £14 million to accelerate quantum technology for health, defence and infrastructure

The UK government has launched a new funding worth over £14 million to drive forward real-world applications of quantum technology.

Paracetamol use in pregnancy not clearly linked to autism or ADHD

A new umbrella review led by the University of Liverpool finds that current studies provide only low-to-critically low evidence linking maternal use of paracetamol during pregnancy to autism spectrum disorder or ADHD in offspring.

Persons with disabilities, belonging on paper and in society?

Millions of persons with disabilities in Asia and the Pacific, particularly children, are legally invisible due to a lack of registration in civil systems. Discover the issues faced by unregistered individuals and how an inclusive Civil Registration and Vital Statistics (CRVS) system can enhance their lives.

DOE invests $625 million to advance U.S leadership in quantum science

The U.S. Department of Energy (DOE) has announced a $625 million investment to renew its five National Quantum Information Science (QIS) Research Centres.

ERC Synergy grant boosts global scientific collaboration

The European Research Council (ERC) has announced the results of its latest Synergy Grant competition, awarding €684 million to 66 international research teams.

New drug targets tumour defences and reverses chemotherapy resistance

Researchers at King’s College London have developed a novel daily pill, KCL‑HO‑1i, that turns off tumour‑guarding macrophages and boosts chemotherapy effectiveness.

New Copernicus satellite launch strengthens Europe’s eye on Earth

Sentinel-1D joins the Copernicus constellation to deliver round-the-clock radar monitoring of our planet.

Engineered biochar offers affordable solution to water pollution

A new study reveals engineered biochar, a modified carbon material from waste biomass, is a powerful and affordable tool for simultaneously removing heavy metals and organic pollutants from wastewater, offering a sustainable solution to complex water pollution.

UK trial launches blood test to improve dementia diagnosis at scale

A major trial led by the University of Bristol and North Bristol NHS Trust is exploring a panel of blood tests to detect dementia faster and more accurately across diverse UK populations.

Decarbonising aviation fuels: The UK perspective

Philip Thomson and James Wyatt at Baker & McKenzie LLP in London provide insight on the UK's approach to decarbonising aviation fuels.

Natural England launches new strategy linking nature recovery and economic growth

Natural England has unveiled a new corporate strategy that aims to place nature at the heart of England's future growth, health, and security.

EIC Board backs 2026 work programme to drive Europe’s deep tech future

The European Innovation Council (EIC) Board has announced that the 2026 Work Programme (WP26) is a key step in advancing Europe’s deep-tech ambitions and strengthening its position as a global leader in innovation.

As classroom mental health cases rises, so must early and proactive intervention

As the number of mental health cases increases in classrooms, early and proactive intervention must also rise, states Ed Robbins, the CEO of Fresh Start in Education.

Xanthommatin: Scientists teach bacteria the octopus’s secret to camouflage

Researchers have engineered bacteria to produce xanthommatin, the pigment that enables cephalopod camouflage. This biotechnological leap creates a sustainable, high-yield method for producing the coveted, colour-changing compound for cosmetics and materials science.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders